Proteases involved in long-term potentiation

被引:68
作者
Tomimatsu, Y
Idemoto, S
Moriguchi, S
Watanabe, S
Nakanishi, H [1 ]
机构
[1] Kyushu Univ, Fac Dent Sci, Div Oral Biol Sci, Lab Oral Aging Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ, Fac Pharmaceut Sci, Grad Sch Pharmacol, Fukuoka 8128582, Japan
关键词
LTP; protease; microglia; NMDA receptor;
D O I
10.1016/S0024-3205(02)02285-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Much attention has been paid to proteases involved in long-term potentiation (LTP). Calpains, Ca-dependent cysteine proteases, have first been demonstrated to be the mediator of LTP by the proteolytic cleavage of fodrin, which allows glutamate receptors located deep in the postsynaptic membrane to move to the surface. It is now generally considered that calpain activation is necessary for LTP formation in the cleavage of substrates such as protein kinase Q, NMDA receptors, and the glutamate receptor-interacting protein. Recent studies have shown that serine proteases such as tissue-type plasminogen activator (tPA), thrombin, and neuropsin are involved in LTP. tPA contributes to UP by both receptor-mediated activation of cAMP-dependent protein kinase and the cleavage of NMDA receptors. Thrombin induces a proteolytic activation of PAR-1, resulting in activation of protein kinase C, which reduces the voltage-dependent Mg2+ blockade of NMDA receptor-channels. On the other hand, neuropsin may act as a regulatory molecule in UP via its proteolytic degradation of extracellular matrix protein such as fibronectin. In addition to such neuronal proteases, proteases secreted from microglia such as tPA may also contribute to LTP. The enzymatic activity of each protease is strictly regulated by endogenous inhibitors and other factors in the brain. Once activated, proteases can irreversibly cleave peptide bonds. After cleavage, some substrates are inactivated and others are activated to gain new functions. Therefore, the issue to identify substrates for each protease is very important to understand the molecular basis of LTP. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 23 条
[11]  
Hrabetova S, 1996, J NEUROSCI, V16, P5324
[12]   Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways [J].
Huang, YY ;
Bach, ME ;
Lipp, HP ;
Zhuo, M ;
Wolfer, DP ;
Hawkins, RD ;
Schoonjans, L ;
Kandel, ER ;
Godfraind, JM ;
Mulligan, R ;
Collen, D ;
Carmeliet, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8699-8704
[13]   MODULATORY EFFECT OF PLASMINOGEN ON NMDA-INDUCED INCREASE IN INTRACELLULAR FREE CALCIUM-CONCENTRATION IN RAT CULTURED HIPPOCAMPAL-NEURONS [J].
INOUE, K ;
KOIZUMI, S ;
NAKAJIMA, K ;
HAMANOUE, M ;
KOHSAKA, S .
NEUROSCIENCE LETTERS, 1994, 179 (1-2) :87-90
[14]   Neuropsin regulates an early phase of Schaffer-collateral long-term potentiation in the murine hippocampus [J].
Komai, S ;
Matsuyama, T ;
Matsumoto, K ;
Kato, K ;
Kobayashi, M ;
Imamura, K ;
Yoshida, S ;
Ugawa, S ;
Shiosaka, S .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (04) :1479-1486
[15]   Proteolysis of glutamate receptor-interacting protein by calpain in rat brain: implications for synaptic plasticity [J].
Lu, XY ;
Wyszynski, M ;
Sheng, M ;
Baudry, M .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (06) :1553-1560
[16]   THE BIOCHEMISTRY OF MEMORY - A NEW AND SPECIFIC HYPOTHESIS [J].
LYNCH, G ;
BAUDRY, M .
SCIENCE, 1984, 224 (4653) :1057-1063
[17]   Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice [J].
Madani, R ;
Hulo, S ;
Toni, N ;
Madani, H ;
Steimer, T ;
Muller, D ;
Vassalli, JD .
EMBO JOURNAL, 1999, 18 (11) :3007-3012
[18]  
Nakagami Y, 2000, J NEUROSCI, V20, P2003
[19]   The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling [J].
Nicole, O ;
Docagne, F ;
Ali, C ;
Margaill, I ;
Carmeliet, P ;
MacKenzie, ET ;
Vivien, D ;
Buisson, A .
NATURE MEDICINE, 2001, 7 (01) :59-64
[20]  
PIANI D, 1994, J IMMUNOL, V152, P3578